Literature DB >> 1522226

The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia.

B P Giroir1, J H Johnson, T Brown, G L Allen, B Beutler.   

Abstract

Tumor necrosis factor (TNF) is a protein hormone implicated in the development of septic shock and other pathologic states. However, complexities inherent in detecting TNF synthesis by individual tissues have left the precise origins of this protein undefined. In addition, the possibility that localized TNF production may contribute to the pathogenesis of organ-specific diseases such as type I diabetes has not been explored in vivo. We have developed a transgenic mouse line bearing a reporter gene construct in which the TNF coding sequence and introns are replaced by a chloramphenicol acetyltransferase (CAT) coding sequence. In normal transgenic animals, CAT activity is expressed only in the thymus. When endotoxin is administered to the animals, CAT activity is also evident in kidney, heart, islets of Langerhans, spleen, lung, fallopian tubes, and uterus, but not in other organs. The biosynthesis of CAT in vivo correlated with tissue capacity to secrete TNF in vitro. Thus, TNF was secreted by all the tissues that expressed CAT, including lung, spleen, thymus, uterus/fallopian tubes, pancreatic islets, renal glomeruli, and cultured cardiac cells after exposure to endotoxin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1522226      PMCID: PMC329918          DOI: 10.1172/JCI115939

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  63 in total

1.  Constitutive synthesis of tumor necrosis factor in the thymus.

Authors:  B P Giroir; T Brown; B Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

2.  TNF-alpha is expressed on the surface of kidney proximal tubular cells.

Authors:  A M Jevnikar; R P Wuthrich; D C Brennan; W Maslinski; L H Glimcher; V E Rubin-Kelley
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

Review 3.  Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy.

Authors:  J E Parrillo; M M Parker; C Natanson; A F Suffredini; R L Danner; R E Cunnion; F P Ognibene
Journal:  Ann Intern Med       Date:  1990-08-01       Impact factor: 25.391

4.  Inhibition of glucose transport into rat islet cells by immunoglobulins from patients with new-onset insulin-dependent diabetes mellitus.

Authors:  J H Johnson; B P Crider; K McCorkle; M Alford; R H Unger
Journal:  N Engl J Med       Date:  1990-03-08       Impact factor: 91.245

5.  A CAT reporter construct allows ultrasensitive estimation of TNF synthesis, and suggests that the TNF gene has been silenced in non-macrophage cell lines.

Authors:  B Beutler; T Brown
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

6.  Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis.

Authors:  P F Piguet; M A Collart; G E Grau; A P Sappino; P Vassalli
Journal:  Nature       Date:  1990-03-15       Impact factor: 49.962

7.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

8.  Constitutive activity of the tumor necrosis factor promoter is canceled by the 3' untranslated region in nonmacrophage cell lines; a trans-dominant factor overcomes this suppressive effect.

Authors:  V Kruys; K Kemmer; A Shakhov; V Jongeneel; B Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

9.  Tumors secreting human TNF/cachectin induce cachexia in mice.

Authors:  A Oliff; D Defeo-Jones; M Boyer; D Martinez; D Kiefer; G Vuocolo; A Wolfe; S H Socher
Journal:  Cell       Date:  1987-08-14       Impact factor: 41.582

10.  Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.

Authors:  P F Piguet; G E Grau; B Allet; P Vassalli
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  33 in total

Review 1.  The role of anti-cytokine therapy in the failing heart.

Authors:  A Deswal; A Misra; B Bozkurt
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

2.  A novel lipopolysaccharide-induced transcription factor regulating tumor necrosis factor alpha gene expression: molecular cloning, sequencing, characterization, and chromosomal assignment.

Authors:  F Myokai; S Takashiba; R Lebo; S Amar
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

3.  Protective role of Ipomoea obscura (L.) on cyclophosphamide-induced uro- and nephrotoxicities by modulating antioxidant status and pro-inflammatory cytokine levels.

Authors:  T P Hamsa; Girija Kuttan
Journal:  Inflammopharmacology       Date:  2010-09-29       Impact factor: 4.473

Review 4.  Transgenic mice in the study of cytokine function.

Authors:  J Taverne
Journal:  Int J Exp Pathol       Date:  1993-12       Impact factor: 1.925

Review 5.  Emerging role for TNF-α in erectile dysfunction.

Authors:  Fernando S Carneiro; Robert Clinton Webb; Rita C Tostes
Journal:  J Sex Med       Date:  2010-12       Impact factor: 3.802

Review 6.  Recent insights into the role of tumor necrosis factor in the failing heart.

Authors:  D L Mann
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

Review 7.  Removal of pro-inflammatory cytokines with renal replacement therapy: sense or nonsense?

Authors:  M Schetz; P Ferdinande; G Van den Berghe; C Verwaest; P Lauwers
Journal:  Intensive Care Med       Date:  1995-02       Impact factor: 17.440

8.  The immunocytochemical localization of tumour necrosis factor and leukotriene in the rat heart and lung during endotoxin shock.

Authors:  N Tanaka; T Kita; K Kasai; T Nagano
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome.

Authors:  Y Harel; M Silva; B Giroir; A Weinberg; T B Cleary; B Beutler
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

10.  Differential cellular immunolocalization of renal tumour necrosis factor-alpha production during ischaemia versus endotoxaemia.

Authors:  K K Donnahoo; X Meng; L Ao; A Ayala; B D Shames; M P Cain; A H Harken; D R Meldrum
Journal:  Immunology       Date:  2001-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.